Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs TRT Kingdom

Queen RX
Graded #192

Higher grade

vs+8.799999999999997
TRT Kingdom
Graded #397

Lower grade

The verdict

Queen RX takes it — 66.3/100 to 57.5/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +32
77
45
Dose & formulationQueen RX +17
57
40
Clinical oversightTRT Kingdom +13
69
82
Labs & monitoringTRT Kingdom +23
53
76
FulfillmentQueen RX +15
75
60
Contract termsQueen RX +20
61
41
Queen RX · left barTRT Kingdom · right bar

The numbers

MetricQueen RXTRT Kingdom
WeighScore66.3/10057.5/100
GradeCC
Scorecard rank#192#397
Semaglutide$100/mo (quarterly plan, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
TRT Kingdom

Graded #397 · C

Strengths

  • Compounded GLP-1 and dual GLP-1/GIP options offered
  • Microdosing protocols available for men and women
  • Prescribed by licensed physician, dispensed from US pharmacy
  • CMO (Daniel Olivero) plus nurse practitioners on staff
  • Clear disclosure that compounded meds are not FDA-approved

Where it loses points

  • Weight loss is secondary to core TRT/hormone focus
  • No pricing published online
  • Specific compounding pharmacy not named
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard